Malaysia: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Malaysia

The Malaysian prophylactic medicaments containing insulin market fell slightly to $X in 2022, which is down by X% against the previous year. Overall, the total consumption indicated a prominent increase from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, consumption increased by X% against 2020 indices. Prophylactic medicaments containing insulin consumption peaked at $X in 2019; however, from 2020 to 2022, consumption failed to regain momentum.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Malaysia

In value terms, prophylactic medicaments containing insulin production contracted slightly to $X in 2022 estimated in export price. Over the period under review, the total production indicated a resilient expansion from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, production increased by X% against 2020 indices. The pace of growth appeared the most rapid in 2013 with an increase of X% against the previous year. Over the period under review, production hit record highs at $X in 2019; however, from 2020 to 2022, production stood at a somewhat lower figure.

Join Us at HANNOVER MESSE 2024

Don’t miss your chance to connect with us directly. Schedule a personal meeting to dive deeper into how solutions.
Hall 002, Stand C10. 22 - 26 April 2024 | Hannover, Germany

Book Your Meeting

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports from Malaysia

In 2022, shipments abroad of medicaments containing insulin but not antibiotics in measured doses increased by X% to X tons, rising for the fourth consecutive year after two years of decline. Overall, exports enjoyed a significant expansion. The most prominent rate of growth was recorded in 2020 when exports increased by X%. Over the period under review, the exports hit record highs in 2022 and are likely to see steady growth in years to come.

In value terms, prophylactic medicaments containing insulin exports soared to $X in 2022. Over the period under review, exports enjoyed a significant increase. The pace of growth was the most pronounced in 2014 with an increase of X%. Over the period under review, the exports hit record highs in 2022 and are expected to retain growth in the immediate term.

Exports by Country

The United States (X tons) was the main destination for prophylactic medicaments containing insulin exports from Malaysia, accounting for a X% share of total exports. Moreover, prophylactic medicaments containing insulin exports to the United States exceeded the volume sent to the second major destination, India (X tons), more than tenfold. The third position in this ranking was held by Canada (X tons), with a X% share.

From 2013 to 2022, the average annual rate of growth in terms of volume to the United States totaled X%. Exports to the other major destinations recorded the following average annual rates of exports growth: India (X% per year) and Canada (X% per year).

In value terms, the United States ($X) remains the key foreign market for medicaments containing insulin but not antibiotics in measured doses exports from Malaysia, comprising X% of total exports. The second position in the ranking was taken by India ($X), with a X% share of total exports. It was followed by Canada, with a X% share.

From 2013 to 2022, the average annual growth rate of value to the United States totaled X%. Exports to the other major destinations recorded the following average annual rates of exports growth: India (X% per year) and Canada (X% per year).

Export Prices by Country

The average prophylactic medicaments containing insulin export price stood at $X per ton in 2022, rising by X% against the previous year. In general, the export price showed a significant increase. The most prominent rate of growth was recorded in 2017 an increase of X%. The export price peaked at $X per ton in 2019; however, from 2020 to 2022, the export prices stood at a somewhat lower figure.

Average prices varied somewhat for the major foreign markets. In 2022, amid the top suppliers, the highest price was recorded for prices to Canada ($X per ton) and India ($X per ton), while the average price for exports to Morocco ($X per ton) and the United States ($X per ton) were amongst the lowest.

From 2013 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to India (X%), while the prices for the other major destinations experienced mixed trend patterns.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports into Malaysia

In 2022, imports of medicaments containing insulin but not antibiotics in measured doses into Malaysia soared to X tons, jumping by X% on 2021 figures. In general, imports recorded a significant expansion. The most prominent rate of growth was recorded in 2017 with an increase of X%. Imports peaked in 2022 and are likely to see gradual growth in the near future.

In value terms, prophylactic medicaments containing insulin imports soared to $X in 2022. Overall, imports continue to indicate a significant expansion. The pace of growth was the most pronounced in 2017 with an increase of X%. Imports peaked in 2022 and are likely to see steady growth in years to come.

Imports by Country

Brazil (X tons), France (X tons) and Germany (X tons) were the main suppliers of prophylactic medicaments containing insulin imports to Malaysia, together accounting for X% of total imports.

From 2012 to 2022, the most notable rate of growth in terms of purchases, amongst the main suppliers, was attained by Brazil (with a CAGR of X%), while imports for the other leaders experienced more modest paces of growth.

In value terms, the largest prophylactic medicaments containing insulin suppliers to Malaysia were Brazil ($X), France ($X) and Germany ($X), together comprising X% of total imports.

Brazil, with a CAGR of X%, recorded the highest rates of growth with regard to the value of imports, in terms of the main suppliers over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The average prophylactic medicaments containing insulin import price stood at $X per ton in 2022, surging by X% against the previous year. In general, the import price enjoyed a resilient increase. The growth pace was the most rapid in 2016 when the average import price increased by X%. As a result, import price attained the peak level of $X per ton. From 2017 to 2022, the average import prices remained at a somewhat lower figure.

There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was Italy ($X per ton), while the price for Spain ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Denmark (X%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :